Archive Newsletter
-
10.10.24 -- Frankly Fran: 5 Keys To Supplier/Purchasing Controls – And Product Quality
10/10/2024
10/10/24 Drug Delivery Leader Newsletter
-
10.07.24 -- Bacterial Endotoxin Testing, Part 2: Prerequisites And Reagent Preparation
10/7/2024
10/07/24 Drug Delivery Leader Newsletter
-
10.04.24 -- Revolutionize Your Drug Delivery With Nanoformed APIs
10/4/2024
10/04/24 Drug Delivery Leader Newsletter
- Best of September: Top 5 Insights In Drug Formulation and Delivery 10/2/2024
-
09.30.24 -- LNP-Delivered mRNA Via Inhalation With Ethris' Carsten Rudolph And Thomas Langenickel
9/30/2024
09/30/24 Drug Delivery Leader Newsletter
-
09.25.24 -- How To Select The Right Medical Device CMO
9/25/2024
09/25/24 Drug Delivery Leader Newsletter
-
09.23.24 -- Rare Disease Targeting And Novel Therapy Delivery With Kymanox' Evan Edwards
9/23/2024
09/23/24 Drug Delivery Leader Newsletter
-
09.16.24 -- FDA Issues Draft Guidance On Use-Related Risk Analysis (URRA)
9/16/2024
09/16/24 Drug Delivery Leader Newsletter
-
09.12.24 -- Frankly Fran: Preparing For The FDA QMSR: Will You Be Ready?
9/12/2024
09/12/24 Drug Delivery Leader Newsletter
-
09.12.24 -- Development Approaches To Meet The Unique Needs Of Pediatric Populations
9/12/2024
09/12/24 Drug Delivery Leader Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more